Evidence map›Paper›PMID 32787590›Full record

ArticleRenal failure2020

Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study.

Aglaia Chalkia, Konstantinos Thomas, Panagiota Giannou, Alexandros Panagiotopoulos, Emilia Hadziyannis, Athanasia Kapota, Harikleia Gakiopoulou, Dimitrios Vassilopoulos, Dimitrios Petras

Open access · goldAbstract read
In one paragraph

Article in Renal failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Aglaia ChalkiaNephrology Department, Hippokration General Hospital, Athens, Greece.
Konstantinos Thomas2nd Department of Medicine and Laboratory, Clinical Immunology - Rheumatology Unit, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Panagiota GiannouNephrology Department, Hippokration General Hospital, Athens, Greece.
Alexandros Panagiotopoulos2nd Department of Medicine and Laboratory, Clinical Immunology - Rheumatology Unit, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Emilia Hadziyannis2nd Department of Medicine and Laboratory, Clinical Immunology - Rheumatology Unit, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Athanasia KapotaNephrology Department, Hippokration General Hospital, Athens, Greece.
Harikleia Gakiopoulou1st Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Dimitrios Vassilopoulos2nd Department of Medicine and Laboratory, Clinical Immunology - Rheumatology Unit, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Dimitrios PetrasNephrology Department, Hippokration General Hospital, Athens, Greece.
National and Kapodistrian University of Athens · GRHippocration General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe complement system has been recently proposed to play an important role in the pathogenesis of ANCA-associated vasculitis (AAV). This study evaluated the value of serum and kidney deposited C3 in predicting renal outcomes in AAV.

methodsThis was a retrospective study of 47 patients with AAV, who were categorized according to their serum C3 levels as hypo- or normo-complementemic and to those with positive or negative kidney biopsy immunofluorescence (IF) for C3. Baseline characteristics as well as progression to end-stage renal disease (ESRD) between the 2 groups were compared.

resultsIn total, 23% (11/47) were hypo-complementemic; these patients were older (74 vs. 65 years,

conclusionAlmost one of four patients with AAV has low C3 levels at diagnosis which is associated with more severe renal disease and worse renal outcomes (ESRD). This should be taken into account in therapeutic and monitoring strategies.

Indexed as

AgedAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisComplement C3CreatinineDisease ProgressionFemaleFluorescent Antibody TechniqueHumansKidneyKidney Failure, ChronicMaleMiddle AgedPrognosisProportional Hazards ModelsRetrospective StudiesComplement C3CreatinineANCAcomplementend-stage renal diseaseglomerulonephritisvasculitis

Identifiers

PMID32787590
PMCPMC7472496
OpenAlexW3049362187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.